Predicine
PrivateLast Round
Series B
Jul 29, 2020
Total Funding Raised
$37.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Predicine is a biotechnology company that develops a cell-free DNA- and cell-free RNA-based liquid biopsy technology for cancer diagnostics and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Predicine Comparables
Compare Predicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucence | 85% | |
| DiaCarta, Inc. | 83% | |
| Precede Biosciences | 82% |
Predicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2020 | ||||
| Series A | Apr 16, 2018 | ||||
| Pre Seed | May 15, 2017 |
Predicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series B, Series A |
| Highlight Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased by 45% MoM.
- Jun 21, 2026
Monthly visitors grew 250% MoM, reaching 2.5K.
Predicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Predicine's valuation, stock price, and market status.
Is Predicine a public or private company?
Predicine is a private company.
What is the current stock price of Predicine?
Predicine is a private company with no public stock price. No recent secondary market data is available.
How much is Predicine worth (valuation)?
Valuation information for Predicine is not publicly available.
Can I buy Predicine stock?
Predicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Predicine's last funding round?
Predicine's most recent funding round was Series B on July 29, 2020.
Who are the main investors in Predicine?
Key investors in Predicine include Shenzhen Sangel Venture Capital.
Will Predicine IPO soon?
No public IPO plans have been announced for Predicine.
How can I track Predicine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Predicine's secondary market activity and sign up for updates.